tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Revenue

Compare
430 Followers

Immunome Revenue

Immunome had a revenue of 0.00 in the quarter ending Dec 31, 2025, with ―. This bring the company's revenue in the last twelve months to 6.94M, Increased -28.29%. In the fiscal year ending Dec 31, 2025, Immunome had annual revenue of 6.94M with -23.23% growth.
Revenue (ttm)
6.94M
Revenue Growth
-4.44%
P/S Ratio
356.30
Revenue/Employee
$52,985
Employees
131
Market Cap
$2.47B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
6.94M-2.10M-23.23%
Dec 31, 2024
9.04M-4.98M-35.50%
Dec 31, 2023
14.02M+∞%
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018